Snot 22 Score Calculator
Calculate the Sino-Nasal Outcome Test score for chronic rhinosinusitis assessment. Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateRhinologic Symptoms
Extra-rhinologic Symptoms
Sleep Dysfunction
Psychological Dysfunction
Score is within normal range. No surgical intervention indicated based on symptoms alone. Continue conservative management if needed and monitor at follow-up visits.
Formula
Each of the 22 items is scored from 0 (no problem) to 5 (problem as bad as it can be). Total score range: 0-110. Scores > 7 are above normal. MCID (minimal clinically important difference) is 8.9 points. Four domains: rhinologic (items 1-8), extra-rhinologic (9-12), sleep (13-17), psychological (18-22).
Last reviewed: January 2026
Worked Examples
Example 1: Pre-Surgical CRS Assessment
Example 2: Post-Treatment Follow-Up
Background & Theory
The Snot-22 Score Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Snot-22 Score Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Sources & References
- 1Hopkins C et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009;34:447-54
- 2Piccirillo JF et al. Psychometric and clinimetric validity of the SNOT-20. Otolaryngol Head Neck Surg 2002;126:41-47
- 3International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021
Formula
SNOT-22 = Sum of 22 items (each scored 0-5)
Each of the 22 items is scored from 0 (no problem) to 5 (problem as bad as it can be). Total score range: 0-110. Scores > 7 are above normal. MCID (minimal clinically important difference) is 8.9 points. Four domains: rhinologic (items 1-8), extra-rhinologic (9-12), sleep (13-17), psychological (18-22).
Worked Examples
Example 1: Pre-Surgical CRS Assessment
Problem: A patient with CRS with nasal polyps rates their symptoms before endoscopic sinus surgery. Key scores: nasal obstruction 5, loss of smell 5, thick discharge 4, post-nasal drip 3, fatigue 4, poor sleep 3, reduced concentration 3. Other items average 2.
Solution: High-scoring items: 5+5+4+3+4+3+3 = 27\nRemaining 15 items at average 2: 15 x 2 = 30\nTotal SNOT-22 = 27 + 30 = 57/110\nRhinologic domain heavily affected\nSleep and psychological domains moderately affected
Result: SNOT-22: 57/110 | Severe | Strong surgical candidate - expected improvement of 20-25 points post-ESS
Example 2: Post-Treatment Follow-Up
Problem: Same patient returns 6 months after surgery. Scores: nasal obstruction 1, loss of smell 2, thick discharge 1, post-nasal drip 1, fatigue 1, poor sleep 1, reduced concentration 1. Other items average 0.5.
Solution: Key items: 1+2+1+1+1+1+1 = 8\nRemaining 15 items at average 0.5: 15 x 0.5 = 7.5 (round to 8)\nTotal SNOT-22 = 8 + 8 = 16/110\nImprovement: 57 - 16 = 41 points\nMCID = 8.9 points\nImprovement far exceeds MCID
Result: SNOT-22: 16/110 | Mild | Improvement of 41 points (exceeds MCID of 8.9) - excellent surgical outcome
Frequently Asked Questions
What is the SNOT-22 and what does it measure?
The Sino-Nasal Outcome Test 22 (SNOT-22) is the most widely used and validated patient-reported outcome measure for chronic rhinosinusitis (CRS). It was developed as an expansion of the earlier SNOT-20 by adding two questions about loss of smell/taste and nasal obstruction, which are critical symptoms of CRS that the original instrument failed to capture. The SNOT-22 consists of 22 questions spanning four domains: rhinologic symptoms (nasal and sinus symptoms), extra-rhinologic symptoms (ear and facial symptoms), sleep dysfunction, and psychological dysfunction. Each question is scored from 0 (no problem) to 5 (problem as bad as it can be), giving a total score range of 0 to 110.
What SNOT-22 score is considered abnormal?
A SNOT-22 total score above 7 is generally considered above the normal range for the healthy population. Studies of healthy control subjects without sinus disease report mean SNOT-22 scores of approximately 7 to 9 points. Scores of 8 to 20 indicate mild symptom burden, scores of 21 to 50 indicate moderate symptoms, and scores above 50 indicate severe disease with significant quality-of-life impairment. However, these severity categories are approximate guides rather than rigid classifications. The mean preoperative SNOT-22 score for patients undergoing endoscopic sinus surgery is typically 42 to 55, indicating that most surgical candidates have moderate to severe symptom burden. Individual item analysis can reveal which specific symptoms are most bothersome.
What is the MCID for the SNOT-22?
The minimal clinically important difference (MCID) for the SNOT-22 total score is 8.9 points, as established by Hopkins and colleagues in 2009. This means that a change of 9 or more points in the total SNOT-22 score represents a difference that patients can perceive as a meaningful improvement or worsening in their condition. The MCID is critical for interpreting treatment outcomes because statistically significant changes may not always be clinically meaningful. When evaluating the success of medical or surgical treatment, clinicians should look for an improvement of at least 8.9 points rather than simply checking for statistical significance. Individual domain MCIDs have also been established but are used less frequently in clinical practice.
How is the SNOT-22 used before and after sinus surgery?
The SNOT-22 is a standard outcome measure used to evaluate the effectiveness of endoscopic sinus surgery (ESS) for chronic rhinosinusitis. It is administered preoperatively to document baseline symptom severity and postoperatively (typically at 3, 6, and 12 months) to quantify improvement. Large prospective studies have shown that ESS produces an average SNOT-22 improvement of 20 to 25 points, with approximately 75 to 85 percent of patients achieving an improvement exceeding the MCID of 8.9 points. The SNOT-22 is also used to identify which patients are most likely to benefit from surgery, as those with higher preoperative scores tend to show greater absolute improvement. Surgeons and insurers increasingly use SNOT-22 scores to help justify surgical intervention.
What are the four domains of the SNOT-22?
The SNOT-22 can be divided into four clinically meaningful subdomains that capture different aspects of disease impact. The rhinologic symptom domain (questions 1-8) includes need to blow nose, sneezing, runny nose, nasal obstruction, loss of smell/taste, cough, post-nasal discharge, and thick nasal discharge. The extra-rhinologic symptom domain (questions 9-12) covers ear fullness, dizziness, ear pain, and facial pain/pressure. The sleep dysfunction domain (questions 13-17) assesses difficulty falling asleep, waking at night, lack of good sleep, waking tired, and fatigue. The psychological dysfunction domain (questions 18-22) measures reduced productivity, reduced concentration, frustration, sadness, and embarrassment. Domain analysis helps identify the primary driver of a patient symptoms.
Can the SNOT-22 differentiate between types of chronic rhinosinusitis?
Yes, research has shown that the SNOT-22 domain pattern can help distinguish between CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP), two phenotypes with different underlying pathophysiology and treatment responses. Patients with CRSwNP tend to score higher on rhinologic symptoms, particularly loss of smell/taste and nasal obstruction, while patients with CRSsNP may score relatively higher on facial pain/pressure and extra-rhinologic symptoms. However, total SNOT-22 scores may be similar between the two groups. These domain-level differences reflect the eosinophilic inflammation and polypoid obstruction characteristic of CRSwNP versus the more pain-predominant presentation of CRSsNP. Understanding domain patterns can guide treatment selection.
References
- Hopkins C et al. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009;34:447-54
- Piccirillo JF et al. Psychometric and clinimetric validity of the SNOT-20. Otolaryngol Head Neck Surg 2002;126:41-47
- International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy